Home › Non-Small Cell Lung Cancer › Idaho
Non-Small Cell Lung Cancer clinical trials in Idaho
18 studies for Non-Small Cell Lung Cancer are looking for participants at sites in Idaho.
Cities in Idaho
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT04267848A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Beacon Cancer Care ( Site 0127), Post Falls
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06623422Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- Kootenai Clinic Cancer Services - Post Falls, Post Falls
- Kootenai Clinic Cancer Services - Sandpoint, Sandpoint
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07388524Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Saint Luke's Cancer Institute - Boise, Boise
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- Saint Luke's Cancer Institute - Fruitland, Fruitland
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06498635Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT03191149A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
- Local Institution - 0509, Coeur d'Alene
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06561386Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
- Kootenai Clinic Cancer Services Coeur d'Alene, Coeur d'Alene
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07028489A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
- Research Site, Boise
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06692738Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
- Saint Alphonsus Regional Medical Center - Boise, Boise
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07195695A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- St. Luke's Cancer Institute, Boise
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06793215Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
- Saint Luke's Cancer Institute - Boise, Boise
- Saint Luke's Cancer Institute - Fruitland, Fruitland
- Saint Luke's Cancer Institute - Meridian, Meridian
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06686771Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT05642572Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
- Saint Alphonsus Health System, Boise
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 19, 2026 · NCT07154706Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06116682Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- and 3 more
RecruitingPhase 2
18 Minutes · All sexes · Updated May 5, 2026 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
- Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
- and 8 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT06616584Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- and 3 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Boise
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.